UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges

Reviews in endocrine & metabolic disorders, 2021-09, Vol.22 (3), p.581-594

2021

Volltextzugriff (PDF)

[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?

Rheumatology (Oxford, England), 2020-04, Vol.59 (4), p.772-778

2020

Volltextzugriff (PDF)

Gastroenteropancreatic neuroendocrine tumours (GEP-NET) – Imaging and staging

Baillière's best practice & research. Clinical endocrinology & metabolism, 2016, Vol.30 (1), p.45-57

2016

Volltextzugriff (PDF)

The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis

Swiss medical weekly, 2018-08, Vol.148, p.w14661

2018

Volltextzugriff (PDF)

Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals

Cancers, 2021-11, Vol.13 (22), p.5776

2021

Volltextzugriff (PDF)

In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study

EJNMMI research, 2024-04, Vol.14 (1), p.37-37, Article 37

2024

Volltextzugriff (PDF)

A Simplified PET/CT Measurement Routine with Excellent Diagnostic Accuracy for the Diagnosis of Giant Cell Arteritis

Diagnostics (Basel), 2022-03, Vol.12 (3), p.728

2022

Volltextzugriff (PDF)

Magnetic Resonance Imaging Findings Corresponding to Vasculitis as Defined via [ 18 F]FDG Positron Emission Tomography or Ultrasound

Diagnostics (Basel), 2023-11, Vol.13 (23), p.3559

2023

Volltextzugriff (PDF)

Spontaneous Remission of Severe Systemic Langerhans Cell Histiocytosis with Bladder Involvement: A Case Study

Case reports in oncology, 2017-10, Vol.10 (3), p.876-884

2017

Volltextzugriff (PDF)

Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study

Rheumatology (Oxford, England), 2019-05, Vol.58 (5), p.792-797

2019

Volltextzugriff (PDF)

Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study

European journal of nuclear medicine and molecular imaging, 2018-12, Vol.45 (13), p.2318-2327

2018

Volltextzugriff (PDF)

Reply: 68 Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication

Journal of Nuclear Medicine, 2022-03, Vol.63 (3), p.493-494

2022

Volltextzugriff (PDF)

Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study

Seminars in arthritis and rheumatism, 2024-06, Vol.66, p.152425-152425, Article 152425

2024

Volltextzugriff (PDF)

68Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication\Reply: 68Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication

The Journal of nuclear medicine (1978), 2022-03, Vol.63 (3), p.493

2022

Volltextzugriff (PDF)

68 Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

Journal of Nuclear Medicine, 2022-02, Vol.63 (2), p.310-315

2022

Volltextzugriff (PDF)

68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

The Journal of nuclear medicine (1978), 2022-02, Vol.63 (2), p.310-315

2022

Volltextzugriff (PDF)

Evaluation of the CCK-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - Final Results of the phase 0 "Lumed" Study

The Journal of nuclear medicine (1978), 2019-05, Vol.60

2019

Volltextzugriff (PDF)

A Case Series of Molecular Imaging of Glucagonoma After Initial Therapy—68Ga-DOTATATE PET/CT Reveals Similar Results as in Neuroendocrine Tumors of Other Origin in Follow-up and Re-evaluation

Clinical nuclear medicine, 2018-04, Vol.43 (4), p.252-255

2018

Volltextzugriff (PDF)

The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children with Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia

Hormone research in paediatrics, 2019-01, Vol.91 (1), p.56-61

2019

Volltextzugriff (PDF)

Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?

The Journal of nuclear medicine (1978), 2019-03, Vol.60 (3), p.393-399

2019

Volltextzugriff (PDF)

Cholecystokinin 2 Receptor Agonist 177 Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study

Journal of Nuclear Medicine, 2020-04, Vol.61 (4), p.520-526

2020

Volltextzugriff (PDF)

Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study

The Journal of nuclear medicine (1978), 2020-04, Vol.61 (4), p.520-526

2020

Volltextzugriff (PDF)

Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging

Clinical nuclear medicine, 2020-09, Vol.45 (9), p.e386

2020

Volltextzugriff (PDF)

Comparison of Glucagon-like-Peptide-1 (GLP-1) receptor PET/CT, SPECT/CT and 3T MRI for the localization of Insulinomas: evaluation of accuracy in a prospective crossover imaging study

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.44

2018

Volltextzugriff (PDF)

Magnetic Resonance Imaging Findings Corresponding to Vasculitis as Defined via [[sup.18]F]FDG Positron Emission Tomography or Ultrasound

Diagnostics (Basel), 2023-11, Vol.13 (23)

2023

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(44)
Berichte
(2)
Bücher
(1)

Sprache

Englisch
(46)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(15)
Patients
(11)
Female
(9)
Male
(9)
Computed Tomography
(7)
Magnetic Resonance Imaging
(7)
Middle Aged
(7)
Aged
(6)
Giant Cell Arteritis
(6)
Radiology, Nuclear Medicine & Medical Imaging
(6)
Tomography
(6)
Tumors
(6)
Cholecystokinin
(5)
Imaging
(5)
Medical Imaging
(5)
Nuclear Medicine
(5)
Oncology
(5)
Positron Emission
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges

[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?

Gastroenteropancreatic neuroendocrine tumours (GEP-NET) – Imaging and staging

The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis

Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals

In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study

A Simplified PET/CT Measurement Routine with Excellent Diagnostic Accuracy for the Diagnosis of Giant Cell Arteritis

Magnetic Resonance Imaging Findings Corresponding to Vasculitis as Defined via [ 18 F]FDG Positron Emission Tomography or Ultrasound

Spontaneous Remission of Severe Systemic Langerhans Cell Histiocytosis with Bladder Involvement: A Case Study

Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study

Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study

Reply: 68 Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication

Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study

68Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication\Reply: 68Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication

68 Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

Evaluation of the CCK-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - Final Results of the phase 0 "Lumed" Study

A Case Series of Molecular Imaging of Glucagonoma After Initial Therapy—68Ga-DOTATATE PET/CT Reveals Similar Results as in Neuroendocrine Tumors of Other Origin in Follow-up and Re-evaluation

The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children with Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia

Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?

Cholecystokinin 2 Receptor Agonist 177 Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study

Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study

Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging

Comparison of Glucagon-like-Peptide-1 (GLP-1) receptor PET/CT, SPECT/CT and 3T MRI for the localization of Insulinomas: evaluation of accuracy in a prospective crossover imaging study

Magnetic Resonance Imaging Findings Corresponding to Vasculitis as Defined via [[sup.18]F]FDG Positron Emission Tomography or Ultrasound

Suchergebnisse filtern